Article
RNF213 R4810K Variant in Suspected Unilateral Moyamoya Disease Predicts Contralateral Progression.
Journal of the American Heart Association - 2 Aug 2022
Ok Taedong, Jung Yo Han, Kim Jinkwon, Park Sang Kyu, Park Goeun, Lee Sujee, Lee Kyung-Yul
Abstract excerpt
Background Early-stage unilateral moyamoya disease (MMD) is difficult to discriminate from isolated intracranial atherosclerotic stenosis, and identification of contralateral progression may aid in the diagnosis of MMD. The RNF213 (ring finger protein 213) R4810K variant is a strong genetic susceptibility factor for MMD; however, the role of contralateral progression in unilateral MMD is unknown. Methods and...
Topics
Join the communities discussing this publication.
